New-Born Screening Market Research Report - Global Forecast till 2025

Global New-Born Screening Market: Information by Product (Reagents and Assay Kits and Instruments), by Technology (Tandem Mass Spectrometry, Immunoassays and Enzymatic Assays, Hearing Screening Technology, DNA Assays and Pulse Oximetry), by Test Type (Dry Blood Spot Test, Hearing Screening Test and Critical Congenital Heart Disease (CCHD) Test), by End User (Hospitals, Maternity and Specialty Clinics and Diagnostic Centers) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2025

ID: MRFR/MED/5099-CR | October 2019 | Region: Global | 141 pages

Market Overview
The Global New-Born Screening Market is expected to register a CAGR of 13.33% to reach USD 1545.98 Million till 2025.
New-born screening involves using devices for screening new-born babies for possibilities of different types of diseases that are not apparent at the time of birth. The rising prevalence of new-born diseases has led to the growth of the new-born screening market in recent years. Factors such as government support along with new-born screening programs and increasing neonatal population contribute to the growth of the market. In addition to this, technological advancements related to new-born screening are expected to fuel the market growth. However, the unreliability of few new-born screening tests, and lack of proper healthcare infrastructure and trained professionals are likely to restrain the market growth over the forecast period.
The key factors responsible for driving the market growth are rising prevalence of diseases in new-born children, increasing neonatal population, increasing expenditure on the healthcare IT sector, and technological advancements. However, the lack of proper healthcare infrastructure and trained professionals is projected to curb the growth of the market.
Market Dynamics
The increasing technological advancements in the healthcare sector are considered to grow the market in the coming years.
New-born screening programs offer a lot of benefits which positively affects the market growth. Governments of different regions are taking up a lot of initiatives and raising awareness about new-born screening and its benefits. Various government and non-government organizations are actively focused on offering better fetal and maternal care options. For example, in June 2018, the American Society of Hematology (ASH) led a campaign to fight sickle cell disease in Africa and urged governments, particularly in Sub-Saharan Africa, to invest in the new-born screening of the disease.
Additionally, several governments are supporting manufacturers to develop new screening tests by relaxing their regulations for the manufacturing and marketing of the products. For instance, in February 2017, the US Food and Drug Administration (FDA) approved the marketing of the seeker system for the screening of four rare lysosomal storage disorders (LSDs) in new-born children. The seeker system is designed to detect diseases such as Fabry, Gaucher, Mucopolysaccharidosis Type I (MPS I), and Pompe. It is also the first new-born screening test allowed to be marketed by the FDA for these disorders. Moreover, the US government has programs such as Screening Quality Assurance Programs and Heritable Disorders Program at Health Resources and Service Administration (HRSA). Therefore, such initiatives and programs by the government as well as non-government organizations support market growth.
Global New-Born Screening Market Share, by Product, 2018 & 2025 (USD MILLION)
 
Source: MRFR Analysis
Segmentation
The Global New-Born Screening Market has been segmented into product, technology, test type, and end user.
The Global New-Born Screening Market by products has been segregated into instruments and reagents and assay kits. The instruments segment is expected to grow owing to the increasing awareness about new-born screening and subsequently increasing the number of new-born screening tests. Various reagent kits and instruments are used in new-born screening and diagnosis of diseases in the early phase.
The Global New-Born Screening Market by technology has been divided into tandem mass spectrometry, DNA assays, electrophoresis, pulse oximetry, immunoassays and enzymatic assays, and hearing screening technology. The tandem mass spectrometry segment is expected to grow owing to the advancement in technology and raising awareness about new-born disorders. Furthermore, the pulse oximetry is anticipated to be the fastest-growing segment in the global new-born screening market by technology.
The Global New-Born Screening Market, by test type, has been classified as dry blood spot test, critical congenital heart disease (CCHD) test, urine test, and hearing screening test. The dry blood spot test is likely to hold a significant share owing to the growing awareness about new-born screening and its benefits and increasing number of new-born diseases. The CCHD test is anticipated to be the fastest-growing segment due to technological advancements, growing cases of congenital disabilities, and increasing government initiatives for new-born screening. According to the report published by the Centers for Disease Control and Prevention, in 2018, the number of cases of congenital disabilities are increasing and affecting one in every 33 babies born in the US each year.
The global new-born screening market, by end user, has been categorized as hospitals, maternity and specialty clinics, diagnostic centers, and others. Hospitals are anticipated to grow owing to the increasing support from governments for research & development carried out by hospitals and medical institutes. Moreover, diagnostic centers are expected to be the fastest-growing segment owing to the increase in the outsourcing of diagnostic services.
Global New-Born Screening Market Share, 2018 (%)
 
Source: MRFR Analysis
Regional Analysis
The global new-born screening market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas are anticipated to hold a significant share in the global new-born screening market. The rising prevalence of congenital disorders in new-born children, increasing neonatal population, and government support are driving the growth of the market in this region. The new-born screening programs are strictly followed everywhere in North America. In the US, new-born screening policies are made by the federal government as well as the state government.
Prominent Players
The Prominent Players in the global new-born  screening market are SCIEX (US), PerkinElmer Inc. (US), Waters (US), Natus Medical Incorporated (US), Masimo Corporation (US), Agilent Technologies Inc. (US), Bio-Rad Laboratories, Inc. (US), Medtronic PLC (Ireland), GENERAL ELECTRIC (Boston), Trivitron Healthcare (India), ZenTech SA (Belgium), and Thermo Fisher Scientific Inc. (US).
Some of the key strategies followed by players operating in the Global New-Born Screening Market were innovation, product development, and acquisition & mergers.

PerkinElmer Inc. accounted for 45.6% of the global newborn screening market share in 2017. It is a market leader in the global new-born screening market. The company operates through business segments, namely, discovery and analytical solutions and diagnostics and provides consumables, informatics, instruments, OEM solutions, reagents, software, and training to customers. The company emphasizes on delivering top quality products with advanced technology. PerkinElmer Inc. is expanding its portfolio by acquiring other market players. For instance, in December 2017, the company acquired EuroIMMUN Medical laboratory diagnostics AG to expand its medical devices business.

Bio-Rad Laboratories, Inc. accounted for the second-largest market share of 14.2% in 2017. The company is one of the major players in the life sciences market and offers instruments, software, consumables, reagents, and content for life sciences research and the healthcare sector. The company offers products related to clinical diagnostics in the newborn screening market. The company has a strong presence in the Americas, Europe, and the Pacific Rim. Bio-rad has a strong distribution network in all major markets. Strategic partnerships, collaborations, and new product launches are playing an essential role in the development of the company.

Natus Medical Incorporated operates in segments, including neurology, newborn care, and otometrics. The company accounted for 13.6% of the total market share in 2017. It offers medical equipment, software, and services for the diagnosis, monitoring, and treatment of diseases. Natus is a market leader in hearing screening devices and the technology market. It holds approximately 70% market share of the newborn hearing screening test market. The company is launching new products in emerging economies to capture untapped markets. America and Europe are important markets for the company, and it generates more than 50% of its revenue from the US.

Market Segmentation
Global New-Born Screening Market, by Product

Reagents and Assay Kits
Instruments

Global New-Born Screening Market, by Technology

Tandem Mass Spectrometry
Immunoassays and Enzymatic Assays
Hearing Screening Technology
DNA Assays
Pulse Oximetry

Global New-Born Screening Market, by Test Type

Dry Blood Spot Test
Hearing Screening Test
Critical Congenital Heart Disease (CCHD) Test

Global New-Born Screening Market, by End User

Hospitals
Maternity and Specialty Clinics
Diagnostic Centers

Global New-Born Screening Market, by Region

Americas

North America

US
Canada

Latin America

Europe

Western Europe

Germany
UK
France
Italy
Spain
Rest of Western Europe

Eastern Europe

Asia-Pacific

China
Japan
India
Australia
South Korea
Rest of Asia-Pacific

Middle East & Africa

Middle East
Africa

Available Additional Customizations

Company Profiles of Other Key Players

MP Biomedicals LLC

Intended Audience

Medical device companies
Contract research manufacturing organizations
Research & development organizations
Academic institutes



Frequently Asked Questions (FAQ) :


The global new-born screening market is projected to reach a valuation of USD 1545.98 MN by 2025.

The global new-born screening market is projected to grow at approximately 13.33% CAGR during forecast period (2019-2025).

North America holds the largest share in the global new-born screening market, followed by Europe and the Asia Pacific, respectively.

PerkinElmer Inc. (US), SCIEX (US), Waters (US), Masimo Corporation (US), Natus Medical Incorporated (US), Agilent Technologies Inc. (US), Medtronic PLC (Ireland), Bio-Rad Laboratories, Inc. (US), GENERAL ELECTRIC (Boston), ZenTech SA (Belgium), Trivitron Healthcare (India), and Thermo Fisher Scientific Inc. (US), are some of the major players operating in the new-born screening market.

License

Single User Enterprise User (Buy Premium Reports Chapterwise)
Currency

USD YEN EURO GBP INR
TABLE OF CONTENT

3.1 Definition 20

3.2 Scope of the Study 20

3.3 Assumptions & Limitations 20

3.3.1 Assumptions 20

3.3.2 Limitations 20

3.4 Market Structure 21

4.1 Research Process 23

4.2 Primary Research 24

4.3 Secondary Research 25

4.4 Market Size Estimation 26

4.5 Forecast Model 26

5.1 Introduction 28

5.2 Drivers 29

5.2.1 Rising Prevalence of Diseases in New-Born Children 29

5.2.2 Government Support and New-Born Screening Programs 29

5.2.3 Increasing Neonatal Population 29

5.2.4 Technological Advancements 30

5.3 Restraints 30

5.3.1 Unreliability of Few New-Born Screening Tests 30

5.3.2 Lack of Proper Healthcare Infrastructure and Trained Professionals 30

5.4 Opportunities 31

5.4.1 Screening of Genetic Diseases 31

5.5 Challenges 31

5.5.1 Heavy Cost of Automation Technology 31

6.1 Porter’s Five Forces Model 33

6.1.1 Bargaining Power of Suppliers 33

6.1.2 Bargaining Power of Buyers 33

6.1.3 Threat of New Entrants 34

6.1.4 Threat of Substitutes 34

6.1.5 Intense Rivalry 34

6.2 Supply Chain Analysis 35

6.2.1 R&D and Designing 35

6.2.2 Manufacturing 35

6.2.3 Distribution & Sales 35

6.2.4 Post-Sales Monitoring 35

7.1 Introduction 37

7.2 Reagents and Assay Kits 38

7.3 Instruments 39

8.1 Introduction 42

8.2 Tandem Mass Spectrometry 43

8.3 Immunoassays and Enzymatic Assays 44

8.4 Hearing Screening Technology 45

8.5 DNA Assays 46

8.6 Pulse Oximetry 47

9.1 Introduction 49

9.2 Dry Blood Spot Test 50

9.3 Hearing Screening Test 51

9.4 Critical Congenital Heart Disease (CCHD) Test 52

10.1 Introduction 54

10.2 Hospitals 55

10.3 Maternity and Specialty Clinics 56

10.4 Diagnostic Centers 56

11.1 Introduction 58

11.2 Americas 59

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.2.1 North America 62

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.2.1.1 U.S. 64

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.2.1.2 Canada 66

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.2.2 South America 68

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.3 Europe 70

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.3.1 Western Europe 72

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.3.1.1 Germany 74

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.3.1.2 France 76

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.3.1.3 UK 78

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.3.1.4 Italy 80

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.3.1.5 Spain 82

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.3.1.6 Rest of Western Europe 84

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.3.2 Eastern Europe 86

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.4 Asia-Pacific 88

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.4.1 Japan 91

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.4.2 China 93

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.4.3 India 95

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.4.4 Australia 97

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.4.5 Republic of Korea 99

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.4.6 Rest of Asia-Pacific 101

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.5 Middle East and Africa 103

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.5.1 Middle East 105

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.5.2 Africa 107

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

12.1 Company Market Share Analysis 110

12.1.1 Introduction 110

13.1 SCIEX 113

13.1.1 Company Overview 113

13.1.2 Financial Overview 113

13.1.3 Products/Services Offered 114

13.1.4 SWOT Analysis 114

13.1.5 Key Developments 114

13.1.6 Key Strategy 114


13.2 PerkinElmer Inc. 115

13.2.1 Company Overview 115

13.2.2 Financial Overview 115

13.2.3 Products/Services Offered 116

13.2.4 SWOT Analysis 116

13.2.5 Key Developments 116

13.2.6 Key strategy 117

13.3 WATERS 118

13.3.1 Company Overview 118

13.3.2 Financial Overview 118

13.3.3 Products/Services Offered 119

13.3.4 SWOT Analysis 119

13.3.5 Key Developments 119

13.3.6 Key strategy 119

13.4 Natus Medical Incorporated 120

13.4.1 Company Overview 120

13.4.2 Financial Overview 120

13.4.3 Products/Services Offered 121

13.4.4 SWOT Analysis 121

13.4.5 Key Developments 121

13.4.6 Key Strategy 121

13.5 Masimo Corporation 122

13.5.1 Company Overview 122

13.5.2 Financial Overview 122

13.5.3 Products/Services Offered 123

13.5.4 SWOT Analysis 123

13.5.5 Key Developments 123

13.5.6 Key Strategy 123

13.6 Agilent Technologies Inc. 124

13.6.1 Company Overview 124

13.6.2 Financial Overview 124

13.6.3 Products/Services Offered 125

13.6.4 SWOT Analysis 125

13.6.5 Key Development 125

13.6.6 Key Strategy 125

13.7 Bio-Rad Laboratories, Inc. 126

13.7.1 Company Overview 126

13.7.2 Financial Overview 126

13.7.3 Products/Services Offered 127

13.7.4 SWOT Analysis 127

13.7.5 Key Development 127

13.7.6 Key Strategy 127

13.8 Medtronic 128

13.8.1 Company Overview 128

13.8.2 Financial Overview 128

13.8.3 Products/Services Offered 129

13.8.4 SWOT Analysis 129

13.8.5 Key Development 129

13.8.6 Key Strategy 129

13.9 GENERAL ELECTRIC COMPANY 130

13.9.1 Company Overview 130

13.9.2 Financial Overview 130

13.9.3 Products/Services Offered 131

13.9.4 SWOT Analysis 131

13.9.5 Key Development 131

13.9.6 Key Strategy 131

13.10 Trivitron Healthcare 132

13.10.1 Financial Overview 132

13.10.2 Products/Services Offered 132

13.10.3 SWOT Analysis 133

13.10.4 Key Development 133

13.10.5 Key Strategy 133

13.11 ZenTech SA 134

13.11.1 Company Overview 134

13.11.2 Financial Overview 134

13.11.3 Products/Services Offered 134

13.11.4 SWOT Analysis 135

13.11.5 Key Development 135

13.11.6 Key Strategy 135


13.12 Thermo Fisher Scientific Inc. 136

13.12.1 Company Overview 136

13.12.2 Financial Overview 136

13.12.3 Products/Services Offered 137

13.12.4 SWOT Analysis 137

13.12.5 Key Development 137

13.12.6 Key Strategy 137

14.1 Discussion Blue Print 139

TABLE 1 MARKET SYNOPSIS 18

TABLE 2 PRIMARY INTERVIEWS 23

TABLE 3 GLOBAL NEW-BORN SCREENING MARKET BY PRODUCT, 2016-2025 (USD MILLION) 37

TABLE 4 GLOBAL NEW-BORN SCREENING MARKET FOR REAGENTS AND ASSAY BY REGION, 2016-2025 (USD MILLION) 38

TABLE 5 GLOBAL NEW-BORN SCREENING MARKET FOR INSTRUMENTS BY REGION, 2016-2025 (USD MILLION) 39

TABLE 6 GLOBAL NEW-BORN SCREENING MARKET FOR INSTRUMENTS BY TYPE, 2016-2025 (USD MILLION) 40

TABLE 7 GLOBAL NEW-BORN SCREENING MARKET BY TECHNOLOGY, 2016-2025 (USD MILLION) 43

TABLE 8 GLOBAL NEW-BORN SCREENING MARKET FOR TANDEM MASS SPECTROMETRY BY REGION, 2016-2025 (USD MILLION) 43

TABLE 9 GLOBAL NEW-BORN SCREENING MARKET FOR IMMUNOASSAY AND ENZYMATIC ASSAYS BY REGION,

2016-2025 (USD MILLION) 44

TABLE 10 GLOBAL NEW-BORN SCREENING MARKET FOR HEARING SCREENING TECHNOLOGY BY REGION, 2016-2025 (USD MILLION) 45

TABLE 11 GLOBAL NEW-BORN SCREENING MARKET FOR DNA ASSAY BY REGION, 2016-2025 (USD MILLION) 46

TABLE 12 GLOBAL NEW-BORN SCREENING MARKET FOR PULSE OXIMETRY BY REGION, 2016-2025 (USD MILLION) 47

TABLE 13 GLOBAL NEW-BORN SCREENING MARKET BY TEST TYPE, 2016-2025 (USD MILLION) 50

TABLE 14 GLOBAL NEW-BORN SCREENING MARKET FOR DRY BLOOD SPOT BY REGION, 2016-2025 (USD MILLION) 50

TABLE 15 GLOBAL NEW-BORN SCREENING MARKET FOR HEARING SCREENING TEST BY REGION, 2016-2025 (USD MILLION) 51

TABLE 16 GLOBAL NEW-BORN SCREENING MARKET FOR CRITICAL CONGENITAL HEART DISEASE TEST BY REGION,

2016-2025 (USD MILLION) 52

TABLE 17 GLOBAL NEW-BORN SCREENING MARKET BY END-USER, 2016-2025 (USD MILLION) 55

TABLE 18 GLOBAL NEW-BORN SCREENING MARKET FOR HOSPITALS BY REGION, 2016-2025 (USD MILLION) 55

TABLE 19 GLOBAL NEW-BORN SCREENING MARKET FOR MATERNITY AND SPECIALTY CLINICS BY REGION, 2016-2025 (USD MILLION) 56

TABLE 20 GLOBAL NEW-BORN SCREENING MARKET FOR DIAGNOSTIC CENTERS BY REGION, 2016-2025 (USD MILLION) 56

TABLE 21 GLOBAL NEW-BORN SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 59

TABLE 22 AMERICAS: NEW-BORN SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 59

TABLE 23 AMERICAS: NEW-BORN SCREENING MARKET, BY PRODUCT, 2016-2025 (USD MILLION) 60

TABLE 24 AMERICAS: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION) 60

TABLE 25 AMERICAS: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 60

TABLE 26 AMERICAS: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2016-2025 (USD MILLION) 61

TABLE 27 AMERICAS: NEW-BORN SCREENING MARKET, BY END-USER, 2016-2025 (USD MILLION) 61

TABLE 28 NORTH AMERICA: NEW-BORN SCREENING MARKET, BY COUNTRY, 2016-2025 (USD MILLION) 62

TABLE 29 NORTH AMERICA: NEW-BORN SCREENING MARKET, BY PRODUCT, 2016-2025 (USD MILLION) 62

TABLE 30 NORTH AMERICA: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION) 62

TABLE 31 NORTH AMERICA: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 63

TABLE 32 NORTH AMERICA: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2016-2025 (USD MILLION) 63

TABLE 33 NORTH AMERICA: NEW-BORN SCREENING MARKET, BY END-USER, 2016-2025 (USD MILLION) 63

TABLE 34 U.S.: NEW-BORN SCREENING MARKET, BY PRODUCT, 2016-2025 (USD MILLION) 64

TABLE 35 U.S.: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION) 64

TABLE 36 U.S.: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 64

TABLE 37 U.S.: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2016-2025 (USD MILLION) 65

TABLE 38 U.S.: NEW-BORN SCREENING MARKET, BY END-USER, 2016-2025 (USD MILLION) 65

TABLE 39 CANADA: NEW-BORN SCREENING MARKET, BY PRODUCT, 2016-2025 (USD MILLION) 66

TABLE 40 CANADA: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION) 66

TABLE 41 CANADA: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 66

TABLE 42 CANADA: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2016-2025 (USD MILLION) 67

TABLE 43 CANADA: NEW-BORN SCREENING MARKET, BY END-USER, 2016-2025 (USD MILLION) 67

TABLE 44 SOUTH AMERICA: NEW-BORN SCREENING MARKET, BY PRODUCT, 2016-2025 (USD MILLION) 68

TABLE 45 SOUTH AMERICA: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION) 68

TABLE 46 SOUTH AMERICA: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 68

TABLE 47 SOUTH AMERICA: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2016-2025 (USD MILLION) 69

TABLE 48 SOUTH AMERICA: NEW-BORN SCREENING MARKET, BY END-USER, 2016-2025 (USD MILLION) 69

TABLE 49 EUROPE: NEW-BORN SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 70

TABLE 50 EUROPE: NEW-BORN SCREENING MARKET, BY PRODUCT, 2016-2025 (USD MILLION) 70

TABLE 51 EUROPE: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION) 71

TABLE 52 EUROPE: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 71

TABLE 53 EUROPE: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2016-2025 (USD MILLION) 71

TABLE 54 EUROPE: NEW-BORN SCREENING MARKET, BY END-USER, 2016-2025 (USD MILLION) 72

TABLE 55 WESTERN EUROPE: NEW-BORN SCREENING MARKET, BY COUNTRY, 2016-2025 (USD MILLION) 72

TABLE 56 WESTERN EUROPE: NEW-BORN SCREENING MARKET, BY PRODUCT, 2016-2025 (USD MILLION 72

TABLE 57 WESTERN EUROPE: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION) 73

TABLE 58 WESTERN EUROPE: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 73

TABLE 59 WESTERN EUROPE: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2016-2025 (USD MILLION) 73

TABLE 60 WESTERN EUROPE: NEW-BORN SCREENING MARKET, BY END-USER, 2016-2025 (USD MILLION) 74

TABLE 61 GERMANY: NEW-BORN SCREENING MARKET, BY PRODUCT, 2016-2025 (USD MILLION) 74

TABLE 62 GERMANY: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION) 74

TABLE 63 GERMANY: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 75

TABLE 64 GERMANY: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2016-2025 (USD MILLION) 75

TABLE 65 GERMANY: NEW-BORN SCREENING MARKET, BY END-USER, 2016-2025 (USD MILLION) 75

TABLE 66 FRANCE: NEW-BORN SCREENING MARKET, BY PRODUCT, 2016-2025 (USD MILLION) 76

TABLE 67 FRANCE: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION) 76

TABLE 68 FRANCE: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 76

TABLE 69 FRANCE: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2016-2025 (USD MILLION) 77

TABLE 70 FRANCE: NEW-BORN SCREENING MARKET, BY END-USER, 2016-2025 (USD MILLION) 77

TABLE 71 UK: NEW-BORN SCREENING MARKET, BY PRODUCT, 2016-2025 (USD MILLION) 78

TABLE 72 UK: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION) 78

TABLE 73 UK: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 78

TABLE 74 UK: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2016-2025 (USD MILLION) 79

TABLE 75 UK: NEW-BORN SCREENING MARKET, BY END-USER, 2016-2025 (USD MILLION) 79

TABLE 76 ITALY: NEW-BORN SCREENING MARKET, BY PRODUCT, 2016-2025 (USD MILLION) 80

TABLE 77 ITALY: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION) 80

TABLE 78 ITALY: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 80

TABLE 79 ITALY: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2016-2025 (USD MILLION) 81

TABLE 80 ITALY: NEW-BORN SCREENING MARKET, BY END-USER, 2016-2025 (USD MILLION) 81

TABLE 81 SPAIN: NEW-BORN SCREENING MARKET, BY PRODUCT, 2016-2025 (USD MILLION) 82

TABLE 82 SPAIN: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION) 82

TABLE 83 SPAIN: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 82

TABLE 84 SPAIN: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2016-2025 (USD MILLION) 83

TABLE 85 SPAIN: NEW-BORN SCREENING MARKET, BY END-USER, 2016-2025 (USD MILLION) 83

TABLE 86 REST OF WESTERN EUROPE: NEW-BORN SCREENING MARKET, BY PRODUCT, 2016-2025 (USD MILLION) 84

TABLE 87 REST OF WESTERN EUROPE: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION) 84

TABLE 88 REST OF WESTERN EUROPE: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 84

TABLE 89 REST OF WESTERN EUROPE: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2016-2025 (USD MILLION) 85

TABLE 90 REST OF WESTERN EUROPE: NEW-BORN SCREENING MARKET, BY END-USER, 2016-2025 (USD MILLION) 85

TABLE 91 EASTERN EUROPE: NEW-BORN SCREENING MARKET, BY PRODUCT, 2016-2025 (USD MILLION) 86

TABLE 92 EASTERN EUROPE: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION) 86

TABLE 93 EASTERN EUROPE: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 86

TABLE 94 EASTERN EUROPE: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2016-2025 (USD MILLION) 87

TABLE 95 EASTERN EUROPE: NEW-BORN SCREENING MARKET, BY END-USER, 2016-2025 (USD MILLION) 87

TABLE 96 ASIA-PACIFIC: NEW-BORN SCREENING MARKET, BY COUNTRY, 2016-2025 (USD MILLION) 88

TABLE 97 ASIA-PACIFIC: NEW-BORN SCREENING MARKET, BY PRODUCT, 2016-2025 (USD MILLION) 89

TABLE 98 ASIA-PACIFIC: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION) 89

TABLE 99 ASIA-PACIFIC: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 89

TABLE 100 ASIA-PACIFIC: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2016-2025 (USD MILLION) 90

TABLE 101 ASIA-PACIFIC: NEW-BORN SCREENING MARKET, BY END-USER, 2016-2025 (USD MILLION) 90

TABLE 102 JAPAN: NEW-BORN SCREENING MARKET, BY PRODUCTS, 2016-2025 (USD MILLION) 91

TABLE 103 JAPAN: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION) 91

TABLE 104 JAPAN: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 91

TABLE 105 JAPAN: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2016-2025 (USD MILLION) 92

TABLE 106 JAPAN: NEW-BORN SCREENING MARKET, BY END-USER, 2016-2025 (USD MILLION) 92

TABLE 107 CHINA: NEW-BORN SCREENING MARKET, BY PRODUCT, 2016-2025 (USD MILLION) 93

TABLE 108 CHINA: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION) 93

TABLE 109 CHINA: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 93

TABLE 110 CHINA: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2016-2025 (USD MILLION) 94

TABLE 111 CHINA: NEW-BORN SCREENING MARKET, BY END-USER, 2016-2025 (USD MILLION) 94

TABLE 112 INDIA: NEW-BORN SCREENING MARKET, BY PRODUCT, 2016-2025 (USD MILLION) 95

TABLE 113 INDIA: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION) 95

TABLE 114 INDIA: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 95

TABLE 115 INDIA: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2016-2025 (USD MILLION) 96

TABLE 116 INDIA: NEW-BORN SCREENING MARKET, BY END-USER, 2016-2025 (USD MILLION) 96

TABLE 117 AUSTRALIA: NEW-BORN SCREENING MARKET, BY PRODUCT, 2016-2025 (USD MILLION) 97

TABLE 118 AUSTRALIA: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION) 97

TABLE 119 AUSTRALIA: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 97

TABLE 120 AUSTRALIA: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2016-2025 (USD MILLION) 98

TABLE 121 AUSTRALIA: NEW-BORN SCREENING MARKET, BY END-USER, 2016-2025 (USD MILLION) 98

TABLE 122 REPUBLIC OF KOREA: NEW-BORN SCREENING MARKET, BY PRODUCT, 2016-2025 (USD MILLION) 99

TABLE 123 REPUBLIC OF KOREA: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION) 99

TABLE 124 REPUBLIC OF KOREA: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 99

TABLE 125 REPUBLIC OF KOREA: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2016-2025 (USD MILLION) 100

TABLE 126 REPUBLIC OF KOREA: NEW-BORN SCREENING MARKET, BY END-USER, 2016-2025 (USD MILLION) 100

TABLE 127 REST OF ASIA-PACIFIC: NEW-BORN SCREENING MARKET, BY PRODUCT, 2016-2025 (USD MILLION) 101

TABLE 128 REST OF ASIA-PACIFIC: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION) 101

TABLE 129 REST OF ASIA-PACIFIC: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 101

TABLE 130 REST OF ASIA-PACIFIC: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2016-2025 (USD MILLION) 102

TABLE 131 REST OF ASIA-PACIFIC: NEW-BORN SCREENING MARKET, BY END-USER, 2016-2025 (USD MILLION) 102

TABLE 132 MIDDLE EAST AND AFRICA: NEW-BORN SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 103

TABLE 133 MIDDLE EAST AND AFRICA: NEW-BORN SCREENING MARKET, BY PRODUCT, 2016-2025 (USD MILLION) 103

TABLE 134 MIDDLE EAST AND AFRICA: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION) 104

TABLE 135 MIDDLE EAST AND AFRICA: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 104

TABLE 136 MIDDLE EAST AND AFRICA: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2016-2025 (USD MILLION) 104

TABLE 137 MIDDLE EAST AND AFRICA: NEW-BORN SCREENING MARKET, BY END-USER, 2016-2025 (USD MILLION) 105

TABLE 138 MIDDLE EAST: NEW-BORN SCREENING MARKET, BY PRODUCT, 2016-2025 (USD MILLION) 105

TABLE 139 MIDDLE EAST: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION) 105

TABLE 140 MIDDLE EAST: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 106

TABLE 141 MIDDLE EAST: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2016-2025 (USD MILLION) 106

TABLE 142 MIDDLE EAST: NEW-BORN SCREENING MARKET, BY END-USER, 2016-2025 (USD MILLION) 106

TABLE 143 AFRICA: NEW-BORN SCREENING MARKET, BY PRODUCT, 2016-2025 (USD MILLION) 107

TABLE 144 AFRICA: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2016-2025 (USD MILLION) 107

TABLE 145 AFRICA: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 107

TABLE 146 AFRICA: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2016-2025 (USD MILLION) 108

TABLE 147 AFRICA: NEW-BORN SCREENING MARKET, BY END-USER, 2016-2025 (USD MILLION) 108

FIGURE 1 GLOBAL NEW-BORN SCREENING MARKET: MARKET STRUCTURE 21

FIGURE 2 RESEARCH PROCESS 23

FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH 26

FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL NEW-BORN SCREENING MARKET 28

FIGURE 5 PORTER’S FIVE FORCES ANALYSIS: GLOBAL NEW-BORN SCREENING MARKET 33

FIGURE 6 SUPPLY CHAIN: GLOBAL NEW-BORN SCREENING MARKET 35

FIGURE 7 GLOBAL NEW-BORN SCREENING MARKET SHARE, BY PRODUCT, 2018 (%) 37

FIGURE 8 GLOBAL NEW-BORN SCREENING MARKET, BY PRODUCT, 2018 & 2025 37

FIGURE 9 GLOBAL NEW-BORN SCREENING MARKET SHARE, BY TECHNOLOGY, 2017 (%) 42

FIGURE 10 GLOBAL NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2018 & 2025 42

FIGURE 11 GLOBAL NEW-BORN SCREENING MARKET SHARE, BY TEST TYPE, 2018 (%) 49

FIGURE 12 GLOBAL NEW-BORN SCREENING MARKET, BY TEST TYPE, 2018 & 2025 49

FIGURE 13 GLOBAL NEW-BORN SCREENING MARKET SHARE, BY END-USER, 2018 (%) 54

FIGURE 14 GLOBAL NEW-BORN SCREENING MARKET, BY END-USER, 2018 & 2025 54

FIGURE 15 GLOBAL NEW-BORN SCREENING MARKET, BY REGION, 2018 & 2025 (USD MILLION) 58

FIGURE 16 GLOBAL NEW-BORN SCREENING MARKET SHARE, BY REGION, 2018 (%) 58

FIGURE 17 AMERICAS: NEW-BORN SCREENING MARKET SHARE, BY REGION, 2018 (%) 59

FIGURE 18 EUROPE: NEW-BORN SCREENING MARKET SHARE, BY REGION, 2018 (%) 70

FIGURE 19 ASIA-PACIFIC: NEW-BORN SCREENING MARKET SHARE, BY COUNTRY, 2018 (%) 88

FIGURE 20 MIDDLE EAST AND AFRICA: NEW-BORN SCREENING MARKET SHARE, BY REGION, 2018 (%) 103

FIGURE 21 GLOBAL NEWBORN SCREENING MARKET, MARKET SHARE ANALYSIS 2018 (%) 110